RUNX1::RUNX1T1 Fusion in Pediatric Acute Myeloid Leukemia: A description of two cases.
doi.org/10.21141/PJP.2023.02
- Author:
Jill Jaime
1
;
Ivy Mae Medalla
2
;
Steffanie Charlyne Tamayo
3
;
Qareem Pido
1
;
Francisco Tria IV
4
;
Ma. Luisa Enriquez
3
;
Jean Kamil Sy
1
;
Reynaldo De Castro Jr.
1
;
Daphne Ang
4
Author Information
1. Philippine Childrens Medical Center, Quezon City, Philippines
2. Eastern Visayas Medical Center, Tacloban City, Leyte, Philippines
3. St. Lukes Medical Center, Quezon City, Philippines
4. Philippine Childrens Medical Center, Quezon City, Philippines;St. Lukes Medical Center, Quezon City, Philippines
- Publication Type:Journal Article
- Keywords:
Pediatric acute myeloid leukemia;
Berlin- Frankfurt-Münster (BFM-87) protocol;
l,AML 15 Medical Research Council protocol
- MeSH:
Next Generation Sequencing;
RUNX1::RUNX1T1 fusion
- From:
Philippine Journal of Pathology
2023;8(1):42-48
- CountryPhilippines
- Language:English
-
Abstract:
RUNX1::RUNX1T1 is a core-binding factor driving fusion gene which arises from t(8;21)(q22;q22). It is one of the
most common chromosomal rearrangements in both pediatric and adult Acute Myeloid Leukemia (AML)
with a reported incidence o 15% in children and young adults. There are few case reports documenting
RUNX1::RUNX1T1 translocation in pediatric AML. Although this is generally associated with a favorable
prognosis, we report two (2) cases of de novo pediatric AML in the Philippines harboring a RUNX1::RUNX1T1
translocation, one eventually relapsed while the other attained remission but succumbed to sepsis.
- Full text:8(1)_8.pdf